Telomerase in cancer: Clinical applications

Annals of Medicine

Volumn 30, Issue 5, 1998, Pages 419-430

  Urquidi, Virginia ^a   Tarin, David ^a   Goodison, Steve ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Human telomerase reverse transcriptase (hTERT); Replicative senescence; Telomerase; Telomere shortening; Tumour

Indexed keywords

TELOMERASE;

AGING; CANCER; CARCINOGENESIS; CELL DEATH; CELL DIVISION; CELL IMMORTALIZATION; DNA REPLICATION; ENZYME ACTIVATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TELOMERE; TUMOR; TUMOR GROWTH;

EID: 0031757138     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899809002483     Document Type: Review

References (179)

1. Watson JD. Origin of concatemeric T4 DNA. Nat New Biol 1972; 239: 197-201.
2. Olovnikov AM. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 1973; 41: 181-90.
3. Greider CW. Telomeres. Curr Opin Cell Biol 1991; 3: 444-51.
4. Shay JW, Wright WE, Werbin H. Defining the molecular mechanisms of human cell immortalization. Biochim Biophys Acta 1991; 1072: 1-7.
5. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol 1992; 225: 951-60.
6. Sager R. Tumor suppressor genes: the puzzle and the promise. Science 1989; 246: 1406-12.
7. Sager R. Senescence as a mode of tumor suppression. Environ Health Perspect 1991; 93: 59-62.
8. Kipling D. The Telomere. Oxford: Oxford University Press; 1995.
9. Blackburn EH, Greider CW, eds. Telomeres. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1995.
10. Greider CW. Telomere length regulation. Annn Rev Biochem 1996; 65: 337-65.
11. Wellinger RJ, Sen D. The DNA structures at the ends of eukaryotic chromosomes. Eur J Cancer 1997; 33: 735-49.
12. Meyne J, Ratliff RL, Moyzis RK. Conservation of the human telomere sequence (TTAGGG)n among vertebrates. Proc Natl Acad Sci USA 1989; 86: 7049-53.
13. McElligott R, Wellinger RJ. The terminal DNA structure of mammalian chromosomes. EMBO J 1997; 16: 3705-14.
14. Wang Y, Patel D. Solution structure of the human telomeric repeat d[(AG3)3] G-tetraplex. Structure 1993; 1: 263-82.
15. Laporte L, Thomas GJ Jr. Structural basis of DNA recognition and mechanism of quadruplex formation by the beta subunit of the Oxytricha telomere binding protein. Biochemistry 1998; 37: 1327-35.
16. Mc Clintock B. The stability of broken ends of chromosomes in Zea mays. Genetics 1941; 26: 234-82.
17. Sandell LL, Zakian VA. Loss of a yeast telomere: arrest, recovery, and chromosome loss. Cell 1993; 75: 729-39.
18. van Steensel B, Smogorzewska A, de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 1998; 92: 401-13.
19. Kirk KE, Harmon BP, Reichardt IK, Sedat JW, Blackburn EH. Block in anaphase chromosome separation caused by a telomerase template mutation. Science 1997; 275: 1478-81.
20. Kurenova EV, Mason JM. Telomere functions. A review. Biochemistry (Mosc) 1997; 62: 1242-53.
21. Shore DA. Telomere position effects and transcriptional silencing in the yeast Saccharomyces cerevisiae. In: Blackburn EH, Greider CW, eds. Telomeres. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1995: 139-91.
22. Blackburn EH. The telomere and telomerase: nucleic acid-protein complexes acting in a telomere homeostasis system. A review. Biochemistry (Mosc) 1997; 62: 1196-201.
23. Marcand S, Gilson E, Shore D. A protein-counting mechanism for telomere length regulation in yeast. Science 1997; 275: 986-90.
24. Shore D. Telomere length regulation: getting the measure of chromosome ends. Biol Chem 1997; 378: 591-7.
25. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985; 43: 405-13.
26. van Steensel B, de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature 1997; 385: 740-3.
27. Shen M, Haggblom C, Vogt M, Hunter T, Lu KP. Characterization and cell cycle regulation of the related human telomeric proteins pin2 and TRF1 suggest a role in mitosis. Proc Natl Acad Sci USA 1997; 94: 13618-23.
28. Smith S, de Lange T. TRF1, a mammalian telomeric protein. Trends Genet 1997; 13: 21-6.
29. Konig P, Fairall L, Rhodes D. Sequence-specific DNA recognition by the Myb-like domain of the human telomere binding protein TRF1: a model for the protein-DNA complex. Nucleic Acids Res 1998; 26: 1731-40.
30. Ray A, Runge KW. The C terminus of the major yeast telomere binding protein Rap1p enhances telomere formation. Mol Cell Biol 1998; 18: 1284-95.
31. Greider CW, Blackburn EH. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 1987; 51: 887-98.
32. Lingner J, Hughes TR, Shevchenko A, Mann M, Lundblad V, Cech TR. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 1997; 276: 561-7.
33. Counter CM, Meyerson M, Eaton EN, Weinberg RA. The catalytic subunit of yeast telomerase. Proc Natl Acad Sci USA 1997; 94: 9202-7.
34. Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955-9.
35. Greenberg RA, Allsopp RC, Chin L, Morin GB, DePinho RA. Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 1998; 16: 1723-30.
36. Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization. Cell 1997; 90: 785-95.
37. Harrington L, Zhou W, McPhail T, et al. Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev 1997; 11: 3109-15.
38. Kilian A, Bowtell DD, Abud HE, et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 1997; 6: 2011-9.
39. Nakayama J, Tahara H, Tahara E, et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 1998; 18: 65-8.
40. Collins K, Greider CW. Tetrahymena telomerase catalyzes nucleolytic cleavage and nonprocessive elongation. Genes Dev 1993; 7: 1364-76.
41. Greene EC, Bednenko J, Shippen DE. Flexible positioning of the telomerase-associated nuclease leads to preferential elimination of nontelomeric DNA. Mol Cell Biol 1998; 18: 1544-52.
42. Weinrich SL, Pruzan R, Ma L, et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 1997; 17: 498-502.
43. Beattie TL, Zhou W, Robinson MO, Harrington L. Reconstitution of human telomerase activity in vitro. Curr Biol 1998; 8: 177-80.
44. Counter CM, Meyerson M, Eaton EN, et al. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 1998; 16: 1217-22.
45. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279: 349-52.
46. Vaziri H, Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 1998; 8: 279-82.
47. Shippen-Lentz D, Blackburn EH. Functional evidence for an RNA template in telomerase. Science 1990; 247: 546-52.
48. Blasco MA, Funk W, Villeponteau B, Greider CW. Functional characterization and developmental regulation of mouse telomerase RNA. Science 1995; 269: 1267-70.
49. Hinkley CS, Blasco MA, Funk WD, et al. The mouse telomerase RNA 5′-end lies just upstream of the telomerase template sequence. Nucleic Acids Res 1998; 26: 532-6.
50. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science 1995; 269: 1236-41.
51. Dokudovskaya SS, Petrov AV, Dontsova OA, Bogdanov AA. Telomerase is an unusual RNA-containing enzyme. A review. Biochemistry (Mosc) 1997; 62: 1206-15.
52. Morin GB. The implications of telomerase biochemistry for human disease. Eur J Cancer 1997; 33: 750-60.
53. Collins K, Kobayashi R, Greider CW. Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell 1995; 81: 677-86.
54. Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F. TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 1997; 88: 875-84.
55. Harrington L, McPhail T, Mar V, et al. A mammalian telomerase-associated protein. Science 1997; 275: 973-7.
56. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991; 256: 271-82.
57. Prowse KR, Greider CW. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA 1995; 92: 4818-22.
58. Bryant JE, Hutchings KG, Moyzis RK, Griffith JK. Measurement of telomeric DNA content in human tissues. Biotechniques 1997; 23: 476-8.
59. Shay JW. Accelerated telomere shortening in bone-marrow recipients (comment). Lancet 1998; 351: 153-4.
60. Wynn RF, Cross MA, Hatton C, et al. Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet 1998; 351: 178-81.
61. Akiyama M, Hoshi Y, Sakurai S, Yamada H, Yamada O, Mizoguchi H. Changes of telomere length in children after hematopoietic stem cell transplantation. Bone Marrow Transplant 1998; 21: 167-71.
62. Soder AI, Hoare SF, Muir S, Going JJ, Parkinson EK, Keith WN. Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 1997; 14: 1013-21.
63. Soder AI, Going JJ, Kaye SB, Keith WN. Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization. Oncogene 1998; 16: 979-83.
64. Yashima K, Ashfaq R, Nowak J, et al. Telomerase activity and expression of its RNA component in cervical lesions. Cancer 1998; 82: 1319-27.
65. Blasco MA, Rizen M, Greider CW, Hanahan D. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet 1996; 12: 200-4.
66. Avilion AA, Piatyszck MA, Gupta J, Shay JW, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996; 56: 645-50.
67. Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res 1998; 58: 1558-61.
68. Tahara H, Yasui W, Nakayama J, et al. Detection of hTRT protein expressing cells in human tumor tissues by immunohistochemical analysis. Proceedings of the AACR 89th Annual Meeting; 1998 March 28-April 1; New Orleans, LA. Philadelphia: American Association for Cancer Research; 1998.
69. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59: 521-9.
70. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992; 11: 1921-9.
71. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci U S A 1994; 91: 2900-1.
72. Nilsson P, Mehle C, Remes K, Roos G. Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene 1994; 9: 3043-8.
73. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-5.
74. Wright WE, Shay JW, Piatyszek MA. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995; 23: 3794-5.
75. Ohyashiki JH, Ohyashiki K, Sano T, Toyama K. Nonradioisotopic and semi-quantitative procedure for terminal repeat amplification protocol. Jpn J Cancer Res 1996; 87: 329-31.
76. Poremba C, Bocker W, Willenbring H, et al. Telomerase activity in human proliferative breast lesions. Int J Oncol 1998; 12: 641-8.
77. Ohyashiki K, Ohyashiki JH, Nishimaki J, et al. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res 1997; 57: 2100-3.
78. Kim NW, Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 1997; 25: 2595-7.
79. Norton JC, Holt SE, Wright WE, Shay JW. Enhanced detection of human telomerase activity. DNA Cell Biol 1998; 17: 217-9.
80. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995; 85: 2315-20.
81. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33: 787-91.
82. Meeker AK, Coffey DS. Telomerase: a promising marker of biological immortality of germ, stem, and cancer cells. A review. Biochemistry (Mosc) 1997; 62: 1323-31.
83. Nakatani K, Yoshimi N, Mori H, et al. The significant role of telomerase activity in human brain tumors. Cancer 1997; 80: 471-6.
84. DeMasters BK, Markham N, Lillehei KO, Shroyer KR. Differential telomerase expression in human primary intracranial tumors. Am J Clin Pathol 1997; 107: 548-54.
85. Langford LA, Piatyszek MA, Xu R, Schold SC Jr, Shay JW. Telomerase activity in human brain tumours. Lancet 1995; 346: 1267-8.
86. Gupta J, Han LP, Wang P, Gallic BL, Bacchetti S. Development of retinoblastoma in the absence of telomerase activity. J Natl Cancer Inst 1996; 88: 1152-7.
87. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 1996; 93: 6476-81.
88. Yasumoto S, Kunimura C, Kikuchi K, et al. Telomerase activity in normal human epithelial cells. Oncogene 1996; 13: 433-9.
89. Ramirez RD, Wright WE, Shay JW, Taylor RS. Telomerase activity concentrates in the mitotically active segments of human hair follicles. J Invest Dermatol 1997; 108: 113-7.
90. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci U S A 1995; 92: 9082-6.
91. Hiyama K, Hirai Y, Kyoizumi S, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711-5.
92. Igarashi H, Sakaguchi N. Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes. Biochem Biophys Res Commun 1996; 219: 649-55.
93. Buchkovich KJ, Greider CW. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Biol Cell 1996; 7: 1443-54.
94. Weng NP, Levine BL, June CH, Hodes RJ. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996; 183: 2471-9.
95. Norrback KF, Dahlenborg K, Carlsson R, Roos G. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas, Blood 1996; 88: 222-9.
96. Yamada O, Motoji T, Mizoguchi H. Up-regulation of telomerase activity in human lymphocytes. Biochim Biophys Acta 1996; 1314: 260-6.
97. Bodnar AG, Kim NW, Effros RB, Chiu CP. Mechanism of telomerase induction during T cell activation. Exp Cell Res 1996; 228: 58-64.
98. Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MA. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 1997; 90: 182-93.
99. Chiu CP, Dragowska W, Kim NW, et al. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 1996; 14: 239-48.
100. Yui J, Chiu CP, Lansdorp PM. Telomerase activity in candidate stem cells from fetal liver and adult bone marrow. Blood 1998; 91: 3255-62.
101. Lee HW, Blasco MA, Gottlieb GJ, Horner JW 2nd, Greider CW, DePinho RA. Essential role of mouse telomerase in highly proliferative organs. Nature 1998; 392: 569-74.
102. Yashima K, Piatyszck MA, Saboorian HM, et al. Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol 1997; 50: 110-7.
103. Brien TP, Kallakury BV, Lowry CV, et al. Telomerase activity in benign endometrium and endometrial carcinoma. Cancer Res 1997; 57: 2760-1.
104. Kyo S, Takakura M, Kohama T, Inoue M. Telomerase activity in human endometrium. Cancer Res 1997; 57: 610-4.
105. Saito T, Schneider A, Martel N, et al. Proliferation-associated regulation of telomerase activity in human endometrium and its potential implication in early cancer diagnosis. Biochem Biophys Res Commun 1997; 231: 610-4.
106. Yokoyama Y, Takahashi Y, Shinohara A, Lian Z, Tamaya T. Telomerase activity in the female reproductive tract and neoplasms. Gynecol Oncol 1998; 68: 145-9.
107. Ramakrishnan S, Eppenberger U, Mueller H, Shinkai Y, Narayanan R. Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res 1998; 58: 622-5.
108. Umbricht CB, Saji M, Westra WH, Udelsman R, Zeiger MA, Sukumar S. Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma. Cancer Res 1997; 57: 2144-7.
109. Kojima H, Yokosuka O, Imazcki F, Saisho H, Omata M. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroentcrology 1997; 112: 493-500.
110. Tahara H, Nakanishi T, Kitamoto M, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995; 55: 2734-6.
111. Nakashio R, Kitamoto M, Tahara H, Nakanishi T, Ide T, Kajiyama G. Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Int J Cancer 1997; 74: 141-7.
112. Suda T, Isokawa O, Aoyagi Y, et al. Quantitation of telomerase activity in hepatocellular carcinoma: a possible aid for a prediction of recurrent diseases in the remnant liver. Hepatology 1998; 27: 402-6.
113. Kyo S, Takakura M, Tanaka M, Kanaya T, Inoue M. Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions. Int J Cancer 1998; 79: 66-70.
114. Leber B, Bacchetti S. Telomeres and telomerase in normal and malignant haematologic cells. Lenk Lymphoma 1996; 24: 1-9.
115. Engelhardt M, Ozkaynak MF, Drullinsky P, et al. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy. Leukemia 1998; 12: 13-24.
116. Sugino T, Yoshida K, Bolodeoku J, et al. Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates. Int J Cancer 1996; 69: 301-6.
117. Aogi K, Kitahara K, Buley I, et al. Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine needle aspirates. Clin Cancer Res 1998; 4: 1965-700.
118. Gorham H, Yoshida K, Sugino T, et al. Telomerase activity in human gynaecological malignancies. J Clin Pathol 1997; 50: 501-4.
119. Kyo S, Takakura M, Ishikawa H, et al. Application of telomerase assay for the screening of cervical lesions. Cancer Res 1997; 57: 1863-7.
120. Zheng PS, Iwasaka T, Yokoyama M, Nakao Y, Pater A, Sugimori H. Telomerase activation in in vitro and in vivo cervical carcinogenesis. Gynecol Oncol 1997; 66: 222-6.
121. Califano J, Ahrendt SA, Meininger G, Westra WH, Koch WM, Sidransky D. Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res 1996; 56: 5720-2.
122. Arai T, Yasuda Y, Takaya T, et al. Application of telomerase activity for screening of primary lung cancer in bronchoalveolar lavage fluid. Oncol Rep 1998; 5: 405-8.
123. Yang CT, Lee MH, Lan RS, Chen JK. Telomerase activity in pleural effusions: diagnostic significance. J Clin Oncol 1998; 16: 567-73.
124. Yoshida K, Sugino T, Goodison S, et al. Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br J Cancer 1997; 75: 548-53.
125. Yoshida K, Sugino T, Tahara H, et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 1997; 79: 362-9.
126. Kavaler E, Landman J, Chang Y, Droller MJ, Liu BC. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity. Cancer 1998; 82: 708-14.
127. Kinoshita H, Ogawa O, Kakehi Y, et al. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J Natl Cancer Inst 1997; 89: 724-30.
128. Linn JF, Lango M, Halachmi S, Schoenberg MP, Sidransky D. Microsatellite analysis and telomerase activity in archived tissue and urine samples of bladder cancer patients. Int J Cancer 1997; 74: 625-9.
129. Iwasaka T, Zheng PS, Yokoyama M, Fukuda K, Nakao Y, Sugimori H. Telomerase activation in cervical neoplasia. Obstet Gynecol 1998; 91: 260-2.
130. Pao CC, Tseng CJ, Lin CY, et al. Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions. J Clin Oncol 1997; 15: 1932-7.
131. Shroyer K, Thompson L, Enomoto T, Eskens J, Shroyer A, McGregor J. Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia, and squamous cell carcinoma of the uterine cervix. Ant J Clin Pathol 1998; 109: 153-62.
132. Scates DK, Muir GH, Venitt S, Carmichael PL. Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer? Br J Urol 1997; 80: 263-8.
133. Zhang W, Kapusta LR, Slingerland JM, Klotz LH. Telomerase activity in prostate cancer, prostatic intra-epithelial neoplasia, and benign prostatic epithelium. Cancer Res 1998; 58: 619-21.
134. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey DS. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 1996; 56: 218-22.
135. Lin Y, Uemura H, Fujinami K, Hosaka M, Harada M, Kubota Y. Telomerase activity in primary prostate cancer. J Urol 1997; 157: 1161-5.
136. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995; 55: 2533-6.
137. Tahara H, Kuniyasu H, Yokozaki H, et al. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res 1995; 1: 1245-51.
138. Mehle C, Piatyszek MA, Ljungberg B, Shay JW, Roos G. Telomerase activity in human renal cell carcinoma. Oncogene 1996; 13: 161-6.
139. Fiedler W, Dahse R, Schlichter A, et al. Telomerase activity and telomere length in different areas of renal cell carcinoma. Int J Oncol 1996; 9: 1227-32.
140. Tahara E, Semba S, Tahara H. Molecular biological observations in gastric cancer. Semin Oncol 1996; 23: 307-15.
141. Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer. Cancer Res 1995; 55: 3258-62.
142. Zhang W, Piatyszek MA, Kobayashi T, et al. Telomerase activity in human acute myelogenous leukemia - inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res 1996; 2: 799-803.
143. Langford LA, Piatyszek MA, Xu R, Schold SC Jr, Wright WE, Shay JW. Telomerase activity in ordinary meningiomas predicts poor outcome. Hum Pathol 1997; 28: 416-20.
144. Hiyama E, Gollahon L, Kataoka T, et al. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996; 88: 116-22.
145. Clark GM, Osborne CK, Levitt D, Wu F, Kim NW. Telomerase activity and survival of patients with node-positive breast cancer. J Natl Cancer Inst 1997; 89: 1874-81.
146. Hoos A, Hepp HH, Kaul S, Ahlert T, Bastert G, Wallwiener D. Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer. Int J Cancer 1998; 79: 8-12.
147. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995; 1: 249-55.
148. Sugino T, Yoshida K, Bolodeoku J, Tarin D, Goodison S. Telomerase activity and its inhibition in benign and malignant breast lesions. J Pathol 1997; 183: 57-61.
149. Katoh M, Katoh M, Kameyama M, Kugoh H, Shimizu M, Oshimura M. A repressor function for telomerase activity in telomerase-negative immortal cells. Mol Carcinog 1998; 21: 17-25.
150. Steenbergen RD, Walboomers JM, Meijer CJ, et al. Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. Oncogene 1996; 13: 1249-57.
151. Ohmura H, Tahara H, Suzuki M, et al. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn J Cancer Res 1995; 86: 899-904.
152. Loughran O, Clark LJ, Bond J, et al. Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene 1997; 14: 1955-64.
153. Parkinson EK, Newbold RF, Keith WN. The genetic basis of human keratinocyte immortalisation in squamous cell carcinoma development: the role of telomerase reactivation. Eur J Cancer 1997; 33: 727-34.
154. Hiyama K, Ishioka S, Shirotani Y, et al. Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene 1995; 10: 937-44.
155. Bacchetti S. Telomere maintenance in tumour cells. Cancer Surv 1996; 28: 197-216.
156. Yu GL, Bradley JD, Attardi LD, Blackburn EH. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 1990; 344: 126-32.
157. Singer MS, Gottschling DE. TLC1: template RNA component of Saccharomyces cerevisiae telomerase. Science 1994; 266: 404-9.
158. McEachern MJ, Blackburn EH. Runaway telomere elongation caused by telomerase RNA gene mutations. Nature 1995; 376: 403-9.
159. Blasco MA, Lee HW, Hande MP, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997; 91: 25-34.
160. Hamilton SE, Pitts AE, Katipally RR, et al. Identification of determinants for inhibitor binding within the RNA active site of human telomerase using PNA scanning. Biochemistry 1997; 36: 11873-80.
161. Mata JE, Joshi SS, Palen B, et al. A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo. Toxicol Appl Pharmacol 1997; 144: 189-97.
162. Zhao JQ, Hoare SF, McFarlane R, et al. Cloning and characterization of human and mouse telomerase RNA gene promoter sequences. Oncogene 1998; 16: 1345-50.
163. Mandal M, Kumar R. Bcl-2 modulates telomerase activity. J Biol Chem 1997; 272: 14183-7.
164. Klingelhutz AJ, Foster SA, McDougall JK. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 1996; 380: 79-82.
165. Stoppler H, Hartmann DP, Sherman L, Schlegel R. The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length. J Biol Chem 1997; 272: 13332-7.
166. Kallassy M, Martel N, Damour O, Yamasaki H, Nakazawa H. Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21WAF1 gene expression. Mol Carcinog 1998; 21: 26-36.
167. Li H, Zhao LL, Funder JW, Liu JP. Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J Biol Chem 1997; 272: 16729-32.
168. Yegorov YE, Chernov DN, Akimov SS, et al. Blockade of telomerase function by nucleoside analogs. Biochemistry (Mosc) 1997; 62: 1296-305.
169. Melana S, Holland J, Pogo B. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3′-azido-3′-deoxythymidine. Clin Cancer Res 1998; 4: 693-6.
170. Yamakuchi M, Nakata M, Kawahara K, Kitajima I, Maruyama I. New quinolones, ofloxacin and levofloxacin, inhibit telomerase activity in transitional cell carcinoma cell lines. Cancer Lett 1997; 119: 213-9.
171. Burger AM, Double JA, Newell DR. Inhibition of telomerase activity by cisplatin in human testicular cancer cells. Eur J Cancer 1997; 33: 638-44.
172. Ishibashi T, Lippard SJ. Telomere loss in cells treated with cisplatin. Proc Natl Acad Sci USA 1998; 95: 4219-23.
173. Murnane JP, Sabatier L, Marder BA, Morgan WF. Telomere dynamics in an immortal human cell line. EMBO J 1994; 13: 4953-62.
174. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995; 14: 4240-8.
175. Rogan EM, Bryan TM, Hukku B, et al. Alterations in p53 and p161NK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol Cell Biol 1995; 15: 4745-53.
176. Reddel RR, Bryan TM, Murnane JP. Immortalized cells with no detectable telomerase activity. A review. Biochemistry (Mosc) 1997; 62: 1254-62.
177. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 1997; 3: 1271-4.
178. Wang SS, Zakian VA. Telomere-telomere recombination provides an express pathway for telomere acquisition. Nature 1990; 345: 456-8.
179. Mason JM, Biessmann H. The unusual telomeres of Drosophila. Trends Genet 1995; 11: 58-62.